Investor Updates

Latest Financial Results

Q3 2023

Quarter Ended September 30, 2023

Latest Annual Filing

For Fiscal Year Ending December 31, 2022

Company Overview

NightHawk Biosciences is the parent company of Scorpius BioManufacturing, an integrated contract development and manufacturing organization (CDMO) that rapidly advances biologic and cell therapy programs to the clinic and beyond. Scorpius offers a broad array analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the art facilities in San Antonio, TX. With an experienced team and new, purpose-built, U.S. facilities, Scorpius is dedicated to easily accessible, transparent collaboration and flexible biologics biomanufacturing

Stock Snapshot

IR Contacts

Headquarters

Nighthawk Biosciences, Inc.
627 Davis Drive
Suite 300
Morrisville, NC 27560
T: +1 919 240 7133
info@nighthawkbio.com

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
T: +1 212 509 4000